{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:02:20Z","timestamp":1777532540596,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,24]]},"DOI":"10.7759\/cureus.65319","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:45:43Z","timestamp":1721889943000},"source":"Crossref","is-referenced-by-count":2,"title":["Exploring Haematological Complications in Cirrhosis of the Liver: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Parav","family":"Tantia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parth","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjeet","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Kadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajvardhan","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj JS","year":"2011","unstructured":"Bajaj JS, Wade JB, Gibson DP, et al.. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011, 106:1646-53. 10.1038\/ajg.2011.157","journal-title":"Am J Gastroenterol"},{"key":"ref2","article-title":"Hepatic cirrhosis","author":"Sharma B","year":"2024","unstructured":"Sharma B, John S. Hepatic cirrhosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14229","article-title":"Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease","volume":"40","author":"Scheiner B","year":"2020","unstructured":"Scheiner B, Semmler G, Maurer F, et al.. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int. 2020, 40:194-204. 10.1111\/liv.14229","journal-title":"Liver Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2020.0478","article-title":"Association of liver cirrhosis severity with anemia: does it matter?","volume":"33","author":"Singh S","year":"2020","unstructured":"Singh S, Manrai M, Parvathi VS, Kumar D, Srivastava S, Pathak B. Association of liver cirrhosis severity with anemia: does it matter?. Ann Gastroenterol. 2020, 33:272-6. 10.20524\/aog.2020.0478","journal-title":"Ann Gastroenterol"},{"key":"ref5","unstructured":"Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis. (2024). Accessed. May 19, 2024: http:\/\/www.elsevier.es\/en-revista-annals-hepatology-16-avance-resumen-severe-anemia-is-associated-with-S1665268123002508."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/145984","article-title":"Rare causes of anemia in liver diseases","volume":"31","author":"Dawidowski J","year":"2022","unstructured":"Dawidowski J, Pietrzak A. Rare causes of anemia in liver diseases. Adv Clin Exp Med. 2022, 31:567-74. 10.17219\/acem\/145984","journal-title":"Adv Clin Exp Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/gastroent14030024","article-title":"Diagnostic approach and pathophysiological mechanisms of anemia in chronic liver disease\u2014an overview","volume":"14","author":"Marginean CM","year":"2023","unstructured":"Marginean CM, Pirscoveanu D, Popescu M, et al.. Diagnostic approach and pathophysiological mechanisms of anemia in chronic liver disease\u2014an overview. Gastroenterol Insights. 2023, 14:327-41. 10.3390\/gastroent14030024","journal-title":"Gastroenterol Insights"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i3.777","article-title":"Anemia in cirrhosis: an underestimated entity","volume":"10","author":"Manrai M","year":"2022","unstructured":"Manrai M, Dawra S, Kapoor R, Srivastava S, Singh A. Anemia in cirrhosis: an underestimated entity. World J Clin Cases. 2022, 10:777-89. 10.12998\/wjcc.v10.i3.777","journal-title":"World J Clin Cases"},{"key":"ref9","unstructured":"Anemia and cirrhosis. a bad combination. (2024). Accessed: May 19, 2024: https:\/\/www.medpagetoday.com\/resource-centers\/focus-on-iron-deficiency-anemia\/anemia-and-cirrhosis-bad-combination\/2776."},{"key":"ref10","unstructured":"Anemia and cirrhosis. possible links and more. (2023). Accessed: May 19, 2024: https:\/\/www.medicalnewstoday.com\/articles\/anemia-and-cirrhosis."},{"key":"ref11","unstructured":"Anemia with liver cirrhosis. what\u2019s the connection?. (2023). Accessed: May 19, 2024: https:\/\/www.healthline.com\/health\/anemia-with-cirrhosis."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.89a.21018","article-title":"Cirrhotic coagulopathy: a rebalanced hemostasis","volume":"89","author":"Singh AD","year":"2022","unstructured":"Singh AD, Mucha SR, Lindenmeyer CC. Cirrhotic coagulopathy: a rebalanced hemostasis. Cleve Clin J Med. 2022, 89:523-33. 10.3949\/ccjm.89a.21018","journal-title":"Cleve Clin J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.23785","article-title":"Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management","volume":"14","author":"Islam R","year":"2022","unstructured":"Islam R, Kundu S, Jha SB, et al.. Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management. Cureus. 2022, 14:e23785. 10.7759\/cureus.23785","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.08.013","article-title":"Platelet function in patients with cirrhosis","volume":"56","author":"Lisman T","year":"2012","unstructured":"Lisman T, Porte RJ. Platelet function in patients with cirrhosis. J Hepatol. 2012, 56:993-4. 10.1016\/j.jhep.2011.08.013","journal-title":"J Hepatol"},{"key":"ref15","article-title":"Thrombocytopenia","author":"Jinna S","year":"2024","unstructured":"Jinna S, Khandhar PB. Thrombocytopenia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S205630","article-title":"Assessment and monitoring of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP): strategies to improve outcomes","volume":"11","author":"Kucukyurt S","year":"2020","unstructured":"Kucukyurt S, Eskazan AE. Assessment and monitoring of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP): strategies to improve outcomes. J Blood Med. 2020, 11:319-26. 10.2147\/JBM.S205630","journal-title":"J Blood Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31312-2","article-title":"Coagulation abnormalities in the cirrhotic patient","volume":"12","author":"Muci\u00f1o-Bermejo J","year":"2013","unstructured":"Muci\u00f1o-Bermejo J, Carrillo-Esper R, Uribe M, M\u00e9ndez-S\u00e1nchez N. Coagulation abnormalities in the cirrhotic patient. Ann Hepatol. 2013, 12:713-24. 10.1016\/S1665-2681(19)31312-2","journal-title":"Ann Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.SJG_486_17","article-title":"Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis","volume":"24","author":"Li J","year":"2018","unstructured":"Li J, Han B, Li H, Deng H, M\u00e9ndez-S\u00e1nchez N, Guo X, Qi X. Association of coagulopathy with the risk of bleeding after invasive procedures in liver cirrhosis. Saudi J Gastroenterol. 2018, 24:220-7. 10.4103\/sjg.SJG_486_17","journal-title":"Saudi J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.016","article-title":"Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-art appraisal","volume":"21","author":"Rautou PE","year":"2023","unstructured":"Rautou PE, Caldwell SH, Villa E. Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-art appraisal. Clin Gastroenterol Hepatol. 2023, 21:2110-23. 10.1016\/j.cgh.2023.04.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1124846","article-title":"Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding","volume":"32","author":"Garbuzenko DV","year":"2016","unstructured":"Garbuzenko DV. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Curr Med Res Opin. 2016, 32:467-75. 10.1185\/03007995.2015.1124846","journal-title":"Curr Med Res Opin"},{"key":"ref21","unstructured":"Cirrhosis of the liver. (2024). Accessed. May 19, 2024: https:\/\/www.uofmhealth.org\/conditions-treatments\/digestive-and-liver-health\/cirrhosis-liver."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100749","article-title":"Innovative approaches to the management of ascites in cirrhosis","volume":"5","author":"Wong F","year":"2023","unstructured":"Wong F. Innovative approaches to the management of ascites in cirrhosis. JHEP Rep. 2023, 5:100749. 10.1016\/j.jhepr.2023.100749","journal-title":"JHEP Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxac030","article-title":"Liver cirrhosis and immune dysfunction","volume":"34","author":"Hasa E","year":"2022","unstructured":"Hasa E, Hartmann P, Schnabl B. Liver cirrhosis and immune dysfunction. Int Immunol. 2022, 34:455-66. 10.1093\/intimm\/dxac030","journal-title":"Int Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.10.056","article-title":"Cirrhosis-associated immune dysfunction: novel insights in impaired adaptive immunity","volume":"50","author":"Liaskou E","year":"2019","unstructured":"Liaskou E, Hirschfield GM. Cirrhosis-associated immune dysfunction: novel insights in impaired adaptive immunity. EBioMedicine. 2019, 50:3-4. 10.1016\/j.ebiom.2019.10.056","journal-title":"EBioMedicine"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos A","year":"2022","unstructured":"Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol. 2022, 19:112-34. 10.1038\/s41575-021-00520-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2008.00893.x","article-title":"Management of leukopenia in kidney and pancreas transplant recipients","volume":"22","author":"Hartmann EL","year":"2008","unstructured":"Hartmann EL, Gatesman M, Roskopf-Somerville J, Stratta R, Farney A, Sundberg A. Management of leukopenia in kidney and pancreas transplant recipients. Clin Transplant. 2008, 22:822-8. 10.1111\/j.1399-0012.2008.00893.x","journal-title":"Clin Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030116","article-title":"Determination of etiology in patients admitted due to isolated leukopenia","volume":"101","author":"Mart G","year":"2022","unstructured":"Mart G, Malkan UY, Buyukasik Y. Determination of etiology in patients admitted due to isolated leukopenia. Medicine (Baltimore). 2022, 101:e30116. 10.1097\/MD.0000000000030116","journal-title":"Medicine (Baltimore)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.06.010","article-title":"Evaluation and management of patients with isolated neutropenia","volume":"50","author":"Newburger PE","year":"2013","unstructured":"Newburger PE, Dale DC. Evaluation and management of patients with isolated neutropenia. Semin Hematol. 2013, 50:198-206. 10.1053\/j.seminhematol.2013.06.010","journal-title":"Semin Hematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000494568","article-title":"Bacterial infections in patients with liver cirrhosis in an internal medicine department","volume":"26","author":"Lameir\u00e3o Gomes C","year":"2019","unstructured":"Lameir\u00e3o Gomes C, Violante Silva R, Carrola P, Presa J. Bacterial infections in patients with liver cirrhosis in an internal medicine department. GE Port J Gastroenterol. 2019, 26:324-32. 10.1159\/000494568","journal-title":"GE Port J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v8.i6.307","article-title":"Bacterial infections in cirrhosis: a critical review and practical guidance","volume":"8","author":"Bunchorntavakul C","year":"2016","unstructured":"Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: a critical review and practical guidance. World J Hepatol. 2016, 8:307-21. 10.4254\/wjh.v8.i6.307","journal-title":"World J Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2021808","article-title":"The evolving challenge of infections in cirrhosis","volume":"384","author":"Bajaj JS","year":"2021","unstructured":"Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N Engl J Med. 2021, 384:2317-30. 10.1056\/NEJMra2021808","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2019.09.011","article-title":"Bacterial infections in cirrhosis: current treatment","volume":"19","author":"Miranda-Zazueta G","year":"2020","unstructured":"Miranda-Zazueta G, Le\u00f3n-Gardu\u00f1o LA, Aguirre-Valadez J, Torre-Delgadillo A. Bacterial infections in cirrhosis: current treatment. Ann Hepatol. 2020, 19:238-44. 10.1016\/j.aohep.2019.09.011","journal-title":"Ann Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.010","article-title":"Management of bacterial and fungal infections in cirrhosis: the MDRO challenge","volume":"75","author":"Fern\u00e1ndez J","year":"2021","unstructured":"Fern\u00e1ndez J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021, 75:S101-17. 10.1016\/j.jhep.2020.11.010","journal-title":"J Hepatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-020-01142-3","article-title":"Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review","volume":"13","author":"Miwa T","year":"2020","unstructured":"Miwa T, Hatano Y, Kochi T, et al.. Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review. Clin J Gastroenterol. 2020, 13:882-90. 10.1007\/s12328-020-01142-3","journal-title":"Clin J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-010-0165-x","article-title":"Autoimmune hemolytic anemia in treatment-naive chronic hepatitis C infection: a case report and review of literature","volume":"3","author":"Basseri RJ","year":"2010","unstructured":"Basseri RJ, Schmidt MT, Basseri B. Autoimmune hemolytic anemia in treatment-naive chronic hepatitis C infection: a case report and review of literature. Clin J Gastroenterol. 2010, 3:237-42. 10.1007\/s12328-010-0165-x","journal-title":"Clin J Gastroenterol"},{"key":"ref36","article-title":"Mechanisms of hemolysis in liver disease","volume":"20","author":"Morse EE","year":"1990","unstructured":"Morse EE. Mechanisms of hemolysis in liver disease. Ann Clin Lab Sci. 1990, 20:169-74.","journal-title":"Ann Clin Lab Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/484903","article-title":"Hepatic manifestations in hematological disorders","volume":"2013","author":"Murakami J","year":"2013","unstructured":"Murakami J, Shimizu Y. Hepatic manifestations in hematological disorders. Int J Hepatol. 2013, 2013:484903. 10.1155\/2013\/484903","journal-title":"Int J Hepatol"},{"key":"ref38","article-title":"Hemolytic anemia","author":"Baldwin C","year":"2024","unstructured":"Baldwin C, Pandey J, Olarewaju O. Hemolytic anemia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref39","article-title":"Acanthocytosis","author":"Shah PR","year":"2024","unstructured":"Shah PR, Grewal US, Hamad H. Acanthocytosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03303-x","article-title":"Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia","volume":"18","author":"Bevilacqua M","year":"2023","unstructured":"Bevilacqua M, De Marco L, Stupia R, et al.. Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia. Intern Emerg Med. 2023, 18:1397-404. 10.1007\/s11739-023-03303-x","journal-title":"Intern Emerg Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-00208-7","article-title":"Autoimmune hemolytic anemia: current knowledge and perspectives","volume":"17","author":"Michalak SS","year":"2020","unstructured":"Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, Wolny-Rokicka E, Nowakowska E, Gil L. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing. 2020, 17:38. 10.1186\/s12979-020-00208-7","journal-title":"Immun Ageing"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10568","article-title":"Spur cells causing severe and transfusion-refractory anemia in patients with acute-on-chronic liver failure","volume":"12","author":"Kedarisetty CK","year":"2020","unstructured":"Kedarisetty CK, Kumar R. Spur cells causing severe and transfusion-refractory anemia in patients with acute-on-chronic liver failure. Cureus. 2020, 12:e10568. 10.7759\/cureus.10568","journal-title":"Cureus"},{"key":"ref43","unstructured":"Erythropoietin. production, purpose, test & levels. (2024). Accessed: May 19, 2024: https:\/\/my.clevelandclinic.org\/health\/articles\/14573-erythropoietin."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/snep.2001.20939","article-title":"Erythropoietin and anemia","volume":"21","author":"Tong EM","year":"2001","unstructured":"Tong EM, Nissenson AR. Erythropoietin and anemia. Semin Nephrol. 2001, 21:190-203. 10.1053\/snep.2001.20939","journal-title":"Semin Nephrol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S61551","article-title":"The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions","volume":"10","author":"Palazzuoli A","year":"2014","unstructured":"Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Giordano N, Nuti R. The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions. Ther Clin Risk Manag. 2014, 10:641-50. 10.2147\/TCRM.S61551","journal-title":"Ther Clin Risk Manag"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/srep39003","article-title":"Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"6","author":"Wang L","year":"2016","unstructured":"Wang L, Gao Z, Chen XP, et al.. Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: a systematic review and meta-analysis. Sci Rep. 2016, 6:39003. 10.1038\/srep39003","journal-title":"Sci Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.21037\/aob-21-23","article-title":"The treatment of immune thrombocytopenia (ITP)\u2014focus on thrombopoietin receptor agonists","volume":"6","author":"Kuter DJ","year":"2021","unstructured":"Kuter DJ. The treatment of immune thrombocytopenia (ITP)\u2014focus on thrombopoietin receptor agonists. Ann Blood. 2021, 6:1-4. 10.21037\/aob-21-23","journal-title":"Ann Blood"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05114-8","article-title":"Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus","volume":"102","author":"Pulani\u0107 D","year":"2023","unstructured":"Pulani\u0107 D, B\u00e1torov\u00e1 A, Bod\u00f3 I, et al.. Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus. Ann Hematol. 2023, 102:715-27. 10.1007\/s00277-023-05114-8","journal-title":"Ann Hematol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/591317","article-title":"Abnormal hematological indices in cirrhosis","volume":"23","author":"Qamar AA","year":"2009","unstructured":"Qamar AA, Grace ND. Abnormal hematological indices in cirrhosis. Can J Gastroenterol. 2009, 23:441-5. 10.1155\/2009\/591317","journal-title":"Can J Gastroenterol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2010.003","article-title":"Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis","volume":"2","author":"Mancino P","year":"2010","unstructured":"Mancino P, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J. Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. Mediterr J Hematol Infect Dis. 2010, 2:e2010003. 10.4084\/MJHID.2010.003","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i23.7306","article-title":"Does antiviral therapy reduce complications of cirrhosis?","volume":"20","author":"Chung GE","year":"2014","unstructured":"Chung GE, Lee JH, Kim YJ. Does antiviral therapy reduce complications of cirrhosis?. World J Gastroenterol. 2014, 20:7306-11. 10.3748\/wjg.v20.i23.7306","journal-title":"World J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261334-exploring-haematological-complications-in-cirrhosis-of-the-liver-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:45:55Z","timestamp":1721889955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261334-exploring-haematological-complications-in-cirrhosis-of-the-liver-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.65319","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}